Tackling Immune Pathogenesis of COVID-19 through Molecular Pharmaceutics

An increasing number of clinical studies worldwide are investigating the repurposing of antiviral, immune-modulatory, and anti-inflammatory agents to face the coronavirus disease-19 (COVID-19) pandemic. Nevertheless, few effective therapies exist to prevent or treat COVID-19, which demands increased...

Descripción completa

Detalles Bibliográficos
Autores principales: Puccetti, Matteo, Costantini, Claudio, Ricci, Maurizio, Giovagnoli, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065592/
https://www.ncbi.nlm.nih.gov/pubmed/33916409
http://dx.doi.org/10.3390/pharmaceutics13040494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065592/
https://www.ncbi.nlm.nih.gov/pubmed/33916409
http://dx.doi.org/10.3390/pharmaceutics13040494

Ejemplares similares